Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1.Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527–1535.VandenbrouckeJP]]RosingJ]]BloemenkampKW&etal;Oral contraceptives and the risk of venous thrombosis.N Engl J Med20013441527-15352.van Grootheest K, Vrieling T. Thromboembolism associated with the new contraceptive Yasmin. BMJ 2003;326:257.van GrootheestK]]VrielingTThromboembolism associated with the new contraceptive Yasmin.BMJ20033262573.Pearce HM, Layton D, Wilton LV, et al. Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin. Br J Clin Pharmacol 2005;60:98–102.PearceHM]]LaytonD]]WiltonLV&etal;Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin.Br J Clin Pharmacol20056098-1024.Mira Y, Morata C, Vayá A, et al. Is Yasmin as safe as other contraceptive pills? Clin Appl Thromb Hemost 2006;12:378–379.MiraY]]MorataC]]VayáA&etal;Is Yasmin as safe as other contraceptive pills?Clin Appl Thromb Hemost200612378-3795.López M, Vayá A, Martínez Triguero ML, et al. Yasmin and venous thromboembolism: new case reports. Clin Hemorheol Microcirc 2009;42:65–69.LópezM]]VayáA]]Martínez TrigueroML&etal;Yasmin and venous thromboembolism: new case reports.Clin Hemorheol Microcirc20094265-69
